IndraLab

Statements

SKL2001 decreases the amount of BRCC3. 1 / 1

| 1

reach

"Furthermore, in reciprocal BRCC36 gain-of-function experiments, treatment with SKL2001 (a specific agonist of the Wnt/β-catenin signalling pathway) reversed the protective effects of BRCC36 overexpression (Fig. 4H, I)."

39227917

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SKL2001 decreases the amount of BRCC3. 1 / 1

INDRA sources:

Databases

Reading